Ultrasonic/piezoelectric technology is the common thread across all five projects, from MEMS energy harvesting (smart-MEMPHIS) to medical diagnostics (LUCA, SOLUS) and NDT inspection (FrictionHarmonics).
VERMON SA
French SME designing and manufacturing ultrasonic transducers for medical imaging, cancer diagnostics, smart catheters, and industrial non-destructive testing.
Their core work
VERMON is a French SME that designs and manufactures ultrasonic transducers and piezoelectric sensor systems. Their core technology — precision ultrasound probes — is applied across medical imaging (cancer diagnostics, intravascular ultrasound), industrial non-destructive testing, and miniaturized implantable devices. In H2020 projects, they consistently serve as the ultrasound hardware specialist, supplying custom transducer arrays and piezoelectric components to multi-partner consortia tackling biomedical and industrial sensing challenges.
What they specialise in
LUCA (thyroid nodule analysis), SOLUS (breast cancer diagnostics), and POSITION-II (intravascular ultrasound catheters) all involve biomedical ultrasound applications.
POSITION-II focused on next-generation smart catheters with IVUS/FFR/ICE capabilities, while smart-MEMPHIS developed miniaturized MEMS piezoelectric systems.
FrictionHarmonics — their only coordinated project — developed automated ultrasound scanning for detecting kissing bonds in friction stir welded materials.
smart-MEMPHIS explored MEMS piezo-based energy harvesting with integrated supercapacitors, extending their piezoelectric expertise beyond sensing into power generation.
How they've shifted over time
VERMON's early H2020 work (2014-2016) centered on piezoelectric fundamentals — MEMS energy harvesting and first forays into combining ultrasound with optical diagnostics for cancer detection (thyroid nodules). By 2018, their focus shifted decisively toward interventional medical devices (smart catheters, IVUS, implantables) and industrial quality control (automated weld inspection). The trajectory shows a company moving from component-level R&D toward integrated, application-ready systems in both healthcare and manufacturing.
VERMON is moving from pure transducer components toward complete integrated sensing systems for minimally invasive medical procedures and automated industrial inspection.
How they like to work
VERMON operates primarily as a specialist partner (4 of 5 projects as participant), contributing ultrasound hardware expertise to larger consortia. They coordinated one SME-focused Innovation Action (FrictionHarmonics), suggesting they can lead when the project aligns closely with their core product. With 72 unique partners across 16 countries, they maintain a wide and diverse network — typical of a component supplier whose technology plugs into many different application domains.
VERMON has collaborated with 72 distinct partners across 16 countries, forming an unusually broad network for an SME of their size. This wide reach reflects their role as a transducer supplier whose components are needed by medical device developers, research hospitals, and industrial integrators across Europe.
What sets them apart
VERMON occupies a rare niche as an SME that both designs and manufactures custom ultrasonic transducers — most competitors are either large corporates (e.g., GE, Olympus) or pure research labs. Their ability to bridge medical and industrial ultrasound applications makes them a versatile partner: the same piezoelectric expertise that builds breast cancer probes also builds weld inspection scanners. For consortium builders, they bring production-ready hardware capability, not just prototypes.
Highlights from their portfolio
- smart-MEMPHISLargest single EC contribution (EUR 1,013,419) — a major investment in MEMS piezoelectric energy harvesting that anchored VERMON's early H2020 portfolio.
- FrictionHarmonicsTheir only coordinated project, applying ultrasound expertise to an unexpected domain — automated kissing bond detection in friction stir welded materials.
- SOLUSCombines ultrasound with optical diagnostics for non-invasive breast cancer screening, demonstrating VERMON's capacity to integrate into multi-modal sensing systems.